Stability of furosemide and chlorothiazide stored in syringes.

Am J Health Syst Pharm

Jeffrey J. Cies, Pharm.D., M.P.H., BCPS (AQ-ID), is Pharmacist, St. Christopher's Hospital for Children, Philadelphia, PA, and Pharmacy Clinical Coordinator, Critical Care, and Infectious Diseases Clinical Pharmacist, Alfred I. duPont Hospital for Children, Wilmington, DE. Wayne S. Moore II, Pharm.D., is Pharmacist, Alfred I. duPont Hospital for Children. Arun Chopra, M.D., is Clinician, NYU Langone Medical Center, and Chief, Section of Critical Care Medicine, NYU School of Medicine, New York, NY. Guizhen Lu, B.S., is Research Assistant; and Robert W. Mason, Ph.D., is Head of Clinical Biochemistry, Nemours Biomedical Research, Alfred I. duPont Hospital for Children.

Published: December 2015

Purpose: The results of a study to determine the stability of solutions of furosemide and chlorothiazide over 96 hours are reported.

Methods: Chlorothiazide and furosemide were diluted in 5% dextrose USP to final concentrations of 10 and 1 mg/mL, respectively, and combined. In addition, sample solutions of chlorothiazide in dextrose, furosemide in dextrose, and dextrose alone were prepared for control purposes. The resulting solutions were analyzed immediately after preparation and 24, 48, 72, and 96 hours later using a liquid chromatography-tandem mass spectroscopy (LC-MS/MS) system with an electrospray ionization source. Mixtures and samples were diluted 10,000-fold prior to LC-MS/MS analysis so that concentrations of both drugs would be within the assay's linear range of detection.

Results: LC-MS/MS analysis showed that chlorothiazide typically eluted at 2.6 minutes and furosemide at 4.8 minutes. Each compound was degraded by exposure to strong ultraviolet light in a time-dependent manner. Both unmixed and mixed solutions retained over 90% of the original concentrations of chlorothiazide and furosemide for up to 96 hours. Furosemide and chlorothiazide are commonly used concomitantly to maximize diuresis in pediatric patients; the study findings suggest that solutions of furosemide and chlorothiazide can be combined in the same syringe without loss of stability for up to 96 hours.

Conclusion: Solutions of chlorothiazide (10 mg/mL) and furosemide (1 mg/mL) stored either separately or together in polypropylene syringes remained stable for up to 96 hours at room temperature and protected from light.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834703PMC
http://dx.doi.org/10.2146/ajhp150023DOI Listing

Publication Analysis

Top Keywords

furosemide chlorothiazide
16
chlorothiazide
9
furosemide
8
solutions furosemide
8
chlorothiazide furosemide
8
solutions chlorothiazide
8
lc-ms/ms analysis
8
solutions
6
stability furosemide
4
chlorothiazide stored
4

Similar Publications

Objectives: To examine the association of novel furosemide versus thiazide diuretic exposure with changes in serum sodium, potassium, and chloride levels among infants with grade 2/3 bronchopulmonary dysplasia (BPD).

Study Design: Retrospective cohort study of infants admitted to a level IV neonatal intensive care unit (NICU) with grade 2/3 BPD. We measured within-subject change in serum sodium, potassium, and chloride before and after diuretic initiation using multivariable regression to adjust for differences in dosing and clinical covariates.

View Article and Find Full Text PDF

5/6 Nephrectomy impairs acute kaliuretic responses and predisposes to postprandial hyperkalemia.

Am J Physiol Renal Physiol

December 2024

Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

The susceptibility of patients with chronic kidney disease to develop postprandial hyperkalemia suggests alterations in normal kidney sodium (Na) and potassium (K) handling, but the exact nature of these changes is largely unknown. To address this, we analyzed the natriuretic and kaliuretic responses to diuretics and acute K loading in rats who underwent 5/6 nephrectomy (5/6Nx) and compared this with the response in sham-operated rats. The natriuretic and kaliuretic responses to furosemide, hydrochlorothiazide, and amiloride were largely similar between 5/6Nx and sham rats except for a significantly reduced kaliuretic response to hydrochlorothiazide in 5/6Nx rats.

View Article and Find Full Text PDF

Loop Diuretics: An Overview of Its History and Evolution.

J Assoc Physicians India

September 2024

Cluster Medical Head, Medical Affairs, Cipla Ltd., Mumbai, Maharashtra, India.

Article Synopsis
  • * Diuretics, used for conditions like hypertension and heart failure, increase water and electrolyte excretion, and their development has evolved since the late 1700s, with a major breakthrough in 1957 when chlorothiazide was introduced.
  • * Loop diuretics, including torsemide, furosemide, and ethacrynic acid, were developed in the 1950s and are powerful treatments for severe fluid overload, but they require careful monitoring due to potential side effects.
View Article and Find Full Text PDF

Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum: The CLOROTIC Trial.

JACC Heart Fail

October 2024

Internal Medicine Department, Hospital d'Olot i Comarcal de la Garrotxa, Avinguda dels Països Catalans Olot, Girona, Spain; Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IrisCC), Ctra. de Roda, Barcelona, Spain.

Article Synopsis
  • The CLOROTIC trial studied the effects of adding hydrochlorothiazide (HCTZ) to furosemide in patients with acute heart failure, showing improved diuretic responses regardless of left ventricular ejection fraction (LVEF) levels.
  • A total of 230 patients were analyzed, with results indicating that HCTZ led to better weight loss and diuretic measures within 72 hours, with no significant impacts on mortality or rehospitalization rates across different LVEF categories.
  • The findings suggest that combining HCTZ with furosemide is an effective approach for enhancing diuretic effectiveness in acute heart failure patients, irrespective of their baseline LVEF.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!